Highlights:- Total Income in Q3 FY23 at Rs. 140.12 crore, up 14.4% from Rs. 122.5 crore in Q3 FY22 During the year,…
Company recommends 15% dividend, Rs. 1.50 per share for FY 22 FY22 Results Highlights:- (Standalone) · Net Profit Reports Y-o-Y…
Highlights:- • Net revenues in Q3 FY22 at Rs. 122.52 crore, up 6.18% from Rs. 115.39 crore in Q3 FY21;…
New Delhi, January 29, 2022: Government is required to stimulate growth and boost investment with confidence from both the public…
Acquisition funded from Internal accruals; Expects turnover of Rs. 150 crore in next 3 years Highlights:- Investment in Cephalosporin plant…
Company recommends dividend of 15% - Rs. 1.5 per share for FY 21 Net Revenues from operations in Q4FY21 at…
New Delhi, February 03, 2021: Net revenues in Q3 FY21 at Rs. 113.26 crore, up 15.56 % from Rs. 98.01…
Company to expand export network to 90 plus countries post EU approval; Becomes a Zero net-debt company Net revenues in…
Becomes a Zero net-debt company paying its outstanding debt to the Financial Institution Net revenues in Q1FY21 at Rs. 103.01…
To soon enter the EU markets with its Dermatology, Gastro and Pain Management products and expand gradually Highlights:- · EU permission will increase…